Table 1.
Top 40 putative BCG-SARS cross-reactions.
| HLA predicted | Peptide source | DFS distance | SARS-CoV-2 peptide presented by | Protein source | |
|---|---|---|---|---|---|
| SARS-CoV-2* | BCG | ||||
| HLA-A*01:01 | CNDPFLGVY | MTAFGVEPY | 1 | HLA-A*0101 | SPIKE |
| HLA-A*01:01 | FSAVGNICY | WTDVKFALI | 1 | HLA-A*01:01 | R1A, R1AB |
| HLA-A*01:01 | GTDLEGNFY | EVDSAFDGY | 1 | HLA-A*01:01 | R1A, R1AB |
| HLA-A*02:01 | FIAGLIAIV | TLAGLLPPV | 1 | HLA-A*02:01 | SPIKE |
| HLA-A*02:01 | FVFLVLLPL | WVFLVNLPL | 1 | HLA-A*02:01 | SPIKE |
| HLA-A*02:01 | GLMWLSYFI | TMWLHVPAV | 1 | HLA-A*02:01 | VME1 |
| HLA-A*02:01 | ILGLPTQTV | IVAALLVTI | 1 | HLA-A*02:01 | R1AB |
| HLA-A*02:01 | IVAGGIVAI | NLTGGIVAL | 1 | HLA-A*02:01 | R1A, R1AB |
| HLA-A*02:01 | KLVNKFLAL | KMAKSVLLA | 1 | HLA-A*02:01 | R1A, R1AB |
| HLA-A*02:01 | TLMNVLTLV | ALVLNLLPI | 1 | HLA-A*02:01 | R1A, R1AB |
| HLA-A*02:01 | YLASGGQPI | LLSAAGVPL | 1 | HLA-A*02:01 | R1A, R1AB |
| HLA-A*11:01 | ATVVIGTSK | GLNVNTLSY | 1 | HLA-A*11:01 | R1AB |
| HLA-A*11:01 | VVNARLRAK | IVASRGAQK | 1 | HLA-A*11:01 | R1AB |
| HLA-A*24:02 | AYANRNRFL | VWAQVRNRL | 1 | HLA-A*24:02 | VME1 |
| HLA-A*24:02 | IFFITGNTL | TFGALAITL | 1 | HLA-A*24:02 | R1A, R1AB |
| HLA-A*24:02 | MFTPLVPFW | IYPPQVALV | 1 | HLA-A*24:02 | R1A, R1AB |
| HLA-A*24:02 | TFNGECPNF | EYLETIHTW | 1 | HLA-A*24:02 | R1A, R1AB |
| HLA-A*24:02 | VFVSNGTHW | SYIAYAPQL | 1 | HLA-A*24:02 | SPIKE |
| HLA-A*24:02 | VYMPASWVM | LYGIFIVWL | 1 | HLA-A*24:02 | R1A, R1AB |
| HLA-A*24:02 | YFMRFRRAF | AWRRLTKVI | 1 | HLA-A*24:02 | R1A, R1AB |
| HLA-A*24:02 | YFPLQSYGF | GWPTWGMIL | 1 | HLA-A*24:02 | SPIKE |
| HLA-B*07:02 | LPNNTASWF | APNSGLVAA | 1 | HLA-B*07:02 | NCAP |
| HLA-B*07:02 | QPGQTFSVL | FPMLQFSLL | 1 | HLA-B*07:02 | R1A, R1AB |
| HLA-B*07:02 | RARSVSPKL | RAATAAMVM | 1 | HLA-B*07:02 | NS7A |
| HLA-B*07:02 | TPRDLGACI | LVVDAARAM | 1 | HLA-B*07:02 | R1A, R1AB |
| HLA-B*40:01 | GEAANFCAL | TEVLAAQHL | 1 | HLA-B*40:01 | R1A, R1AB |
| HLA-B*40:01 | GEVITFDNL | SEVVVFDAA | 1 | HLA-B*40:01 | R1A, R1AB |
| HLA-B*40:01 | SELLTPLGI | AEMTVALLL | 1 | HLA-B*40:01 | R1A, R1AB |
| HLA-B*40:01 | WEPEFYEAM | AELEAQQEL | 1 | HLA-B*40:01 | R1AB |
| HLA-A*11:01 | QVVDMSMTY | AQPTEPVLK | 1 | HLA-A*01:01, HLA-A*11:01 | R1A, R1AB |
| HLA-A*11:01 | SASKIITLK | ASGAKTGAK | 1 | HLA-A*03:01, HLA-A*11:01 | AP3A |
| HLA-A*24:02 | VYFLQSINF | VYSVLLALL | 1 | HLA-A*24, HLA-A*24:02 | AP3A |
| HLA-A*24:02 | YFVVKRHTF | VFPGRKGGF | 1 | HLA-A*24:02, HLA-B*08:01 | R1AB |
| HLA-B*07:02 | FPRGQGVPI | DPRGNPVPL | 1 | HLA-B*07:02, HLA-B*08:01 | NCAP |
| HLA-B*35:01 | FAYANRNRF | MASAARLAA | 1 | HLA-B*15:01, HLA-B*35:01 | VME1 |
| HLA-B*35:01 | SANNCTFEY | QPALFTVEY | 1 | HLA-A*29:02, HLA-B*35:01 | SPIKE |
| HLA-B*40:01 | NELSRVLGL | VEGQTNHML | 1 | HLA-B*40:01, HLA-B*44:02 | R1A, R1AB |
| HLA-B*35:01 | TSNQVAVLY | IAAMLLVIY | 1 | HLA-A*26:01, HLA-B*35:01, HLA-B*57:01 | SPIKE |
| HLA-B*40:01 | AEIRASANL | AEPRATGHI | 1 | HLA-B*40:01, HLA-B*44:02, HLA-B*44:03 | SPIKE |
| HLA-A*01:01 | LTDEMIAQY | MTNDNLEYY | 1 | HLA-A*01:01, HLA-A*29:02, HLA-B*35:01, HLA-C*07:02 | SPIKE |
*Immunogenic SARS-CoV-2 peptides.